Journal of Neurology

, Volume 259, Issue 12, pp 2743–2745 | Cite as

Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders

Letter to the Editors
First Online:
Received:
Revised:
Accepted:

Keywords

Celiac Disease Neuromyelitis Optica Methylmalonic Acid Gastric Parietal Cell Subacute Combine Degeneration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Conflicts of interest

The work of B.W. was supported by research grants from Merck Serono and from Bayer HealthCare. The work of S.J. was supported by a Fellowship from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). F.P. was supported by the German Research Foundation (DFG Exc 257) and has received travel reimbursement from the Guthy Jackson Charitable Foundation.

Ethical standard

This study has been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

References

  1. 1.
    Bergamaschi R, Jarius S, Robotti M, Pichiecchio A, Wildemann B, Meola G (2009) Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol 256:2097–2099PubMedCrossRefGoogle Scholar
  2. 2.
    Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68:1076–1077PubMedCrossRefGoogle Scholar
  3. 3.
    Jarius S, Jacob S, Waters P, Jacob A, Littleton E, Vincent A (2008) Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4. J Neurol Neurosurg Psychiatry 79:1084PubMedCrossRefGoogle Scholar
  4. 4.
    Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17:1067–1073PubMedCrossRefGoogle Scholar
  5. 5.
    Jarius S, Paul F, Franciotta D, de Seze J, Munch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger KP, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler 18:1135–1143PubMedCrossRefGoogle Scholar
  6. 6.
    Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202–214PubMedGoogle Scholar
  7. 7.
    Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291:52–56PubMedCrossRefGoogle Scholar
  8. 8.
    Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383–392PubMedCrossRefGoogle Scholar
  9. 9.
    Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78:1601–1607PubMedCrossRefGoogle Scholar
  10. 10.
    Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477PubMedCrossRefGoogle Scholar
  11. 11.
    Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112PubMedCrossRefGoogle Scholar
  12. 12.
    Pennypacker LC, Allen RH, Kelly JP, Matthews LM, Grigsby J, Kaye K, Lindenbaum J, Stabler SP (1992) High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 40:1197–1204PubMedGoogle Scholar
  13. 13.
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:78–83PubMedCrossRefGoogle Scholar
  14. 14.
    Surtees R (1993) Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain. J Inherit Metab Dis 16:762–770PubMedCrossRefGoogle Scholar
  15. 15.
    Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren’s syndrome. Arthritis Rheum 62:1198–1200PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Division of Molecular Neuroimmunology, Department of NeurologyUniversity Hospital HeidelbergHeidelbergGermany
  2. 2.NeuroCure Clinical Research CenterCharité - University Medicine BerlinBerlinGermany
  3. 3.Department of NeurologyCharité - University Medicine BerlinBerlinGermany

Personalised recommendations